Delivering tertiary tuberculosis care virtually.
Where this comes from
- Record sourced from PubMed, PMID 34158279.
- Also identified by DOI 10.1136/archdischild-2020-320421.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To assess the impact of a virtual multidisciplinary team (MDT) review panel in reducing travel for children with a rare disease (tuberculosis (TB)) without compromising clinical outcomes. Retrospective review of patients discussed in a virtual MDT panel. Independent pre-intervention and post-intervention data from Public Health England. Paediatric departments across North West England. Children aged <16 years with suspected TB infection/disease. Weekly, virtual MDT discussion between district paediatricians and a tertiary TB team. Care closer to home, time from presentation to treatment. 45% (37 of 82) children received care closer to home. Median time from presentation to treatment reduced by 28% (from 18 to 13 days). 21% more children were diagnosed before developing symptoms (76% of children presented with symptoms pre-intervention, 55% post-intervention). 5 children incorrectly labelled with latent TB infection were treated for TB disease. A clinical network supported by virtual MDT reviews can improve treatment for children with rare diseases while providing care close to home.
Medical subject headings
- Delivery of Health Care
- Health Services Accessibility
- Telemedicine
- Tuberculosis